Market research
SH0.F Shionogi & Co., Ltd
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 13B
- P/E ratio
- 11.44
- Analyst target
- Not available
- Dividend yield
- 2.6%
- Beta
- 0.03
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- JP3347200002
- Market cap
- 13B
- P/E ratio
- 11.44
- Analyst target
- Not available
- Dividend yield
- 2.6%
- Beta
- 0.03
About
About Shionogi & Co., Ltd
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SH0.F discussion.
5 years, 5 months ago
Shionogi & Co., Ltd is currently in a long term uptrend where the price is trading 15.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.9.
Shionogi & Co., Ltd's total revenue sank by 18.0% to $76B since the same quarter in the previous year.
Its net income has dropped by 6.5% to $37B since the same quarter in the previous year.
Finally, its free cash flow fell by 53.2% to $5B since the same quarter in the previous year.
Based on the above factors, Shionogi & Co., Ltd gets an overall score of 2/5.